CYTOO Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

CYTOO General Information

Description

Developer of cell analysis technology designed to control the cellular microenvironment. The company's technology focuses on the life sciences research community and the culture platform that significantly enhances the physiological relevance of cellular models in comparison to standard techniques used by most laboratories, enabling clients to simply convert poorly predictable and low throughput assays, into reliable and data-rich high content screening efforts.

Contact Information

Website
www.cytoo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 7 parvis Louis Néel, CS 20050
  • Minatec - BHT - Bât. 52
  • 38040 Grenoble
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CYTOO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 0000 Completed Generating Revenue
5. Later Stage VC (Series D) 06-Dec-2012 00.000 0000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 21-Nov-2011 000.00 0000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 27-Sep-2011 00.000 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 28-Sep-2009 $4.64M $6.05M 000.00 Completed Startup
1. Early Stage VC (Series A) 30-Sep-2008 $1.41M $1.41M 00.000 Completed Startup
To view CYTOO’s complete valuation and funding history, request access »

CYTOO Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series C 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series B 359,841 $0.100000 8% $8.85 $8.85 1x $8.85 10.97%
Series A 264,785 $0.100000 8% $3.72 $3.72 1x $3.72 8.07%
To view CYTOO’s complete cap table history, request access »

CYTOO Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell analysis technology designed to control the cellular microenvironment. The company's technology focuse
Biotechnology
Grenoble, France
20 As of 2020
0000
000000 - 000 0000

00000000

do consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
000000000 00000 (0000000000)
Ann Arbor, MI
000 As of 0000
0000 0000-00-00
000000&0

000000 0

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
000000000 00000 (0000000000)
Palo Alto, CA
00 As of 0000
00000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CYTOO Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IncuCyte Formerly PE-Backed Ann Arbor, MI 000 000000&0
000000 00000000000 Venture Capital-Backed Palo Alto, CA 00 00000 00000
00000000 Private Debt Financed Mountain View, CA 00 000000000 -
000000000 00000000 Angel-Backed Huntsville, AL 00 00.000 0000000000 0 00.000
0000000 00000000 Formerly VC-backed London, United Kingdom 0 00.000 000000&0 00.000
You’re viewing 5 of 7 competitors. Get the full list »

CYTOO Executive Team (13)

Name Title Board Seat Contact Info
Luc Selig Ph.D Chief Executive Officer
Wilfried Dang Chief Business Officer
Olivier Pasquier Chief Commercial Officer
Matthieu Piel Co-Founder & Advisor
You’re viewing 4 of 13 executive team members. Get the full list »

CYTOO Board Members (5)

Name Representing Role Since
Marc Le Bozec CYTOO Chairman 000 0000
You’re viewing 1 of 5 board members. Get the full list »

CYTOO Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CYTOO Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Entrepreneurs Fund Family Office Minority 000 0000 000000 0
Auriga Partners (Paris) Venture Capital Minority 000 0000 000000 0
Jacques Lewiner Angel (individual) Minority 000 0000 000000 0
To view CYTOO’s complete investors history, request access »